Revelation Historical Financial Ratios
| REVB Stock | USD 2.76 0.07 2.47% |
Revelation Biosciences is promptly reporting on over 90 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 2.9 K, Invested Capital of 0.0, Average Payables of 656.5 K or Stock Based Compensation To Revenue of 0.0 will help investors to properly organize and evaluate Revelation Biosciences financial condition quickly.
Revelation |
About Revelation Financial Ratios Analysis
Revelation BiosciencesFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Revelation Biosciences investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Revelation financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Revelation Biosciences history.
Revelation Biosciences Financial Ratios Chart
Add Fundamental
Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Payables Turnover
A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.Most ratios from Revelation Biosciences' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Revelation Biosciences current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.At present, Revelation Biosciences' PTB Ratio is projected to increase significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 2,883, whereas Free Cash Flow Yield is projected to grow to (1.4 K).
| 2022 | 2023 | 2024 | 2025 (projected) | Current Ratio | 1.22 | 2.18 | 3.4K | 3.6K | Net Debt To EBITDA | 0.48 | 125.95 | 8.15E-4 | 7.74E-4 |
Revelation Biosciences fundamentals Correlations
Click cells to compare fundamentals
Revelation Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Revelation Biosciences fundamentals Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Ptb Ratio | 428.8 | (16.2K) | 54.52 | 8.24 | 0.002688 | 0.002823 | |
| Book Value Per Share | 393.75 | (10.58) | 58.57 | 29.16 | 2.7K | 2.9K | |
| Pb Ratio | 428.8 | (16.2K) | 54.52 | 8.24 | 0.002688 | 0.002823 | |
| Roic | (0.001887) | 141.82 | (10.29) | (1.3) | (1.2) | (1.14) | |
| Net Income Per Share | (188.18) | (1.3K) | (600.77) | (0.53) | (8.8K) | (8.3K) | |
| Pe Ratio | (897.21) | (134.4) | (5.32) | (455.68) | (8.42E-4) | (8.84E-4) | |
| Return On Tangible Assets | (0.35) | (5.87) | (1.96) | (0.009847) | (2.27) | (2.38) | |
| Earnings Yield | (0.001115) | (0.007441) | (0.19) | (0.002195) | (1.2K) | (1.1K) | |
| Tangible Book Value Per Share | 393.75 | (10.58) | 58.57 | 29.16 | 2.7K | 2.9K | |
| Shareholders Equity Per Share | 393.75 | (10.58) | 58.57 | 29.16 | 2.7K | 2.9K | |
| Graham Net Net | 439.6 | (92.22) | 44.64 | 28.19 | 2.7K | 2.8K | |
| Enterprise Value Over E B I T D A | (10.0K) | (134.89) | (4.81) | (449.6) | (7.72E-4) | (8.11E-4) | |
| Price Earnings Ratio | (897.21) | (134.4) | (5.32) | (455.68) | (8.42E-4) | (8.84E-4) | |
| Price Book Value Ratio | 428.8 | (16.2K) | 54.52 | 8.24 | 0.002688 | 0.002823 | |
| Company Equity Multiplier | 1.35 | (20.53) | 5.23 | 1.84 | 1.41 | 1.48 | |
| Return On Capital Employed | (0.0426) | 120.14 | (10.32) | (1.3) | (1.2) | (1.14) | |
| Price To Book Ratio | 428.8 | (16.2K) | 54.52 | 8.24 | 0.002688 | 0.002823 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Revelation Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. For information on how to trade Revelation Stock refer to our How to Trade Revelation Stock guide.You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Revelation Biosciences. If investors know Revelation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Revelation Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Revelation Biosciences is measured differently than its book value, which is the value of Revelation that is recorded on the company's balance sheet. Investors also form their own opinion of Revelation Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Revelation Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Revelation Biosciences' market value can be influenced by many factors that don't directly affect Revelation Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Revelation Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Revelation Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Revelation Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.